Latest Breaking News On - Advanced solid tumours - Page 1 : comparemela.com

Imugene Limited: Imugene s oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024

Imugene Limited: Imugene s oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New south walesUnited statesSan diegoMatt wrightDaneng liLeslie chongHeather armstrongYoutube imugenelimitedDennis riedlLinkedin imugeneImugene limitedDepartment of medical oncology therapeutics researchAmerican association for cancer researchAmerican associationCancer researchAnnual meeting

Five at Five AU: ASX jumps 1 04% as tech and coal stocks gain ground

Five at Five AU: ASX jumps 1 04% as tech and coal stocks gain ground
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

United statesElon muskWeebit nanoLeslie chongJonathan jacksonLas vegasProvaris energyIsland pharmaceuticals ltdInformation technologyImugene ltdAura energyRio tintoIsland pharmaceuticalsXero ltdCobalt blue holdings ltdProvaris energy ltd

Imugene achieves complete response with mid dose cancer trial

Imugene achieves complete response with mid dose cancer trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoLeslie chongJonathan jacksonImugene ltdAmerican society of clinical oncologyAdvanced solid tumoursComplete responsePartial responsesAmerican societyClinical oncologyCancer symposium

Imugene Ltd doses first patients of VAXINIA MAST combination trial

Imugene Ltd (ASX:IMU, OTC:IUGNF) welcomes the news that the first patients have been dosed in its Phase 1 MAST (metastatic advanced solid tumours) study.

United statesLeslie chongImugene ltdDose escalation safetyTolerability studyAdministered intratumorallyAdult patientsAdvanced solid tumours

Imugene Ltd gets ethics green light to start Australian Phase 1 trial of oncolytic virotherapy candidate VAXINIA

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received Human Research Ethics Committee (HREC) approval to kick off an Australian Phase 1 clinical trial of its.

Leslie chongImugene ltdHuman research ethics committeeTasman oncology researchDrug administrationTherapeutic goods administrationAustralian phaseClinical trials notification schemeDose escalation safetyTolerability studyAdministered intratumorallyAdult patientsAdvanced solid tumours